COMMITMENTS AND CONTINGENCIES (Details) |
3 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Feb. 03, 2022
USD ($)
|
Sep. 14, 2021
USD ($)
|
Aug. 23, 2017
action
defendant
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
case
|
Dec. 31, 2020
USD ($)
|
|
| Legal matters | ||||||
| Legal contingency accrual | $ 3,400,000 | $ 0 | ||||
| Loss on contingency provision | $ 10,600,000 | |||||
| Insurance reimbursement | $ 5,000,000 | |||||
| Securities Class Action Lawsuit | ||||||
| Legal matters | ||||||
| Number of defendants | defendant | 2 | |||||
| Number of shareholder derivative actions filed | action | 5 | |||||
| Multidistrict Opioid Litigation | ||||||
| Legal matters | ||||||
| Number of industry-wide opioid litigation cases (more than) | case | 2,000 | |||||
| Glumetza Antitrust Litigation | ||||||
| Legal matters | ||||||
| Litigation settlement, amount awarded to other party | $ 3,150,000 | |||||
| Glumetza Antitrust Litigation | Subsequent Event | ||||||
| Legal matters | ||||||
| Litigation settlement, amount awarded to other party | $ 3,850,000 |